AI System Expands Dermatology Capacity by 62%, Safely Screening Low-Risk Skin Lesions
An autonomous AI device (AIaMD) screened over 8,500 patients in UK hospitals, safely identifying low-risk skin lesions and freeing up 2,851 clinician hours while maintaining 98% sensitivity for melanoma and other skin cancers.
Technology